Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for XRAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -11.00M
March 31, 2026 -119.00M
December 31, 2025 -99.00M
September 30, 2025 -36.00M
June 30, 2025 -68.00M
March 31, 2025 123.00M
December 31, 2024 -38.00M
September 30, 2024 -79.00M
June 30, 2024 -171.00M
March 31, 2024 -14.00M
December 31, 2023 -128.00M
September 30, 2023 -109.00M
June 30, 2023 -87.00M
March 31, 2023 17.00M
December 31, 2022 -161.00M
September 30, 2022 -6.00M
June 30, 2022 -152.00M
March 31, 2022 -10.00M
December 31, 2021 -122.00M
September 30, 2021 -179.00M
June 30, 2021 -25.00M
March 31, 2021 -53.00M
December 31, 2020 -1.00M
September 30, 2020 -35.20M
June 30, 2020 658.10M
Date Value
March 31, 2020 -129.90M
December 31, 2019 -95.80M
September 30, 2019 -160.80M
June 30, 2019 -110.30M
March 31, 2019 -99.20M
December 31, 2018 -78.60M
September 30, 2018 -82.40M
June 30, 2018 -69.40M
March 31, 2018 -19.40M
December 31, 2017 -232.20M
September 30, 2017 -22.10M
June 30, 2017 -78.90M
March 31, 2017 -67.60M
December 31, 2016 -112.30M
September 30, 2016 237.10M
June 30, 2016 -177.80M
March 31, 2016 -472.80M
December 31, 2015 -8.80M
September 30, 2015 -55.54M
June 30, 2015 -138.05M
March 31, 2015 -20.00M
December 31, 2014 -71.81M
September 30, 2014 -90.93M
June 30, 2014 -117.97M
March 31, 2014 -55.44M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Align Technology, Inc. -67.45M
Envista Holdings Corp. -60.70M
Milestone Scientific, Inc. 1.462M
Sonendo, Inc. --
Integra LifeSciences Holdings Corp. -0.818M